Skip to content

Vicryl Rapide

by Johnson & Johnson International Belgium EUDAMED

Ref V81HModel Vicryl Rapide

EMDN H010101020201,H010101020202

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number0705031a012094L Basic UDI-DIDate12 Mar 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/MDR Active

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • MDR 730044 Supplemented

    Technical documentation EU MDR

    Notified body
    Notified body 2797
    Issued
    10 Sep 2026
    Expires
    19 Dec 2027
    Reason
    Change approved

Specification

EUDAMED · synced 24 Oct 2026

Device Name
VICRYL RAPIDE (Polyglactin 910) Synthetic Absorbable Suture
Model / Reference
Vicryl Rapide, V81H
Primary DI / UDI-DI
10705031110151
Basic UDI-DI
0705031a012094L
EMDN Code
H010101020201,H010101020202
Device Class
Class III
Market of Registration
Belgium

Manufacturer details

EUDAMED SRN
BE-MF-000008018

Other devices from Johnson & Johnson International

See all devices from Johnson & Johnson International →

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
  • Implantable
Other properties (11)
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 10705031110151|0705031A012094L 61 fields · synced 24 Oct 2026